Browsing: Access3

Tumour cells harness multiple resistance mechanisms to evade the host-tumour immune system. Notably, the programmed death 1 (PD1) receptor and…

Asthma is one of the most common chronic respiratory conditions treated in the primary care setting in Singapore. Critically, it…

Disease burden and treatment landscape Breast cancer is the leading cause of death among Singaporean women and accounts for over…

The disease burden and current treatment landscape Atopic dermatitis (AD), or eczema, is the most common skin disorder in Singapore…

Obesity: The Disease Burden and Current Treatment Landscape Obesity is a chronic relapsing disease defined as abnormal or excessive fat…

The disease burden and current treatment landscape Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease with complex clinical manifestations…

The Disease Burden Esketamine (Spravato) by Johnson and Johnson, received local market authorization in October 2021 for use ‘with an…

Disease Burden and Current Treatment Landscape In June 2020, upadacitinib hemihydrate (Rinvoq; AbbVie), an oral reversible JAK1 selective inhibitor received…

Migraine headache is a complex neurobiological disorder that is debilitating for many of its sufferers. Despite its long history, it…

As we progress into 2022, the world continues its battle against COVID-19, with yet another new strain – Omicron, that…